Yahoo Finance’s Anjalee Khemlani joins Zack Guzman to discuss the NIH clinical trial that indicates Remdesivir accelerates the recovery of patients with the coronavirus.
...
Yahoo Finance’s Anjalee Khemlani joins Zack Guzman to break down the findings of the NIH clinical trial that indicate remdesivir accelerates the recovery of patients with COVID-19. ...
Tesla Inc (NASDAQ: TSLA) traded higher by 2.5% on Wednesday ahead of the company's first-quarter earnings report due out after the market close.Glenn Tongue, general partner of Deerhaven Capital Management, said Wednesday that Tesla's curious amended 10-K filing on Tuesday may suggest that the company is planning to announce another offering."My guess is that the company is running desperately low on cash and will announce an offering quickly after the earnings report," Tongue said.He also criticized Tesla's decision to have CEO Elon Musk personally provide directors and officers insurance for board members after the coverage became too expensive for the company."This is unprecedented based on my experience and introduces numerous conflicts, making a mockery of the concept of corporate governance at Tesla," Tongue said.Musk's Big Payday Tongue said new disclosures that Musk is borrowing money against the value of his Tesla stock and using a large portion of that money to...
(Bloomberg) -- The U.S. government’s top infectious-disease expert said that early results of a closely watched clinical trial offered “quite good news” regarding a potential Covid-19 therapy made by the biotechnology company Gilead Sciences Inc.Anthony Fauci, the head of National Institute of Allergy and Infectious Diseases, which is conducting the study, said at a White House meeting with President Donald Trump and Louisiana Governor John Bel Edwards that the trial showed a significant positive effect in treating the virus.Early Wednesday morning, Gilead issued a news release saying it had become aware of results from the NIAID trial showing its experimental drug remdesivir helped patients recover more quickly than standard care, suggesting it could become the first effective treatment for an illness that has turned modern life inside-out.NIAID’s trial enrolled more than 1,000 patients internationally and compared remdesivir treatment alongside supportive care with a placebo. Patients who got the drug recovered in...
